Skip to main content
. Author manuscript; available in PMC: 2019 Jan 15.
Published in final edited form as: Clin Cancer Res. 2017 Nov 7;24(2):306–315. doi: 10.1158/1078-0432.CCR-17-1100

Table 4.

Adverse Events in Intent To Treat Population

Control Low-dose
(500 mg/daily)
High-dose
(4000 mg/daily)
Total
Number of patients 23 55 47 125
Patients experiencing adverse events 19
(83%)
38
(69%)
32
(68%)
89
(71%)
Adverse events (definitely related) 0 0 1 1
Adverse events (probably related) 1 2 0 3
Adverse events (possibly related) 3 8 10 21

Patients may have experienced more than one AE.